4P Independent validation of the PAM50-based chemoendocrine...

Annals of Oncology 2020 / 05 Vol. 31

4P Independent validation of the PAM50-based chemoendocrine score (CES) as pathologic complete response (pCR) and disease-free survival (DFS) predictor in hormone receptor (HR)+/HER2+ breast cancer (BC)

Pascual, T., Fernandez-Martinez, A., Tanioka, M., Dieci, M.V., Pernas Simon, S., Gavila Gregori, J., Guarneri, V., Cortés, J., Villagrasa, P., Vidal, M.J., Adamo, B., Muñoz, M., Griguolo, G., Llomba
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.03.140
Date:
May, 2020
File:
PDF, 85 KB
2020
Conversion to is in progress
Conversion to is failed